UA98676C2 - Композиция зиботентана, содержащая маннит и микрокристаллическую целлюлозу - Google Patents

Композиция зиботентана, содержащая маннит и микрокристаллическую целлюлозу

Info

Publication number: UA98676C2
Authority: UA; Ukraine
Prior art keywords: microcrystalline cellulose; zibotentan; composition containing; containing mannitol; mannitol
Prior art date: 2007-10-12

Application number

UAA201005506A

Other languages

English (en)

Ukrainian (uk)

Inventor

Джон Девид Блай

Эндрю Джон Дей

Киран Джеймс Леннон

Original Assignee

Астразенека Аб

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-12

Filing date

2008-10-09

Publication date

2012-06-11

2008-10-09 Application filed by Астразенека Аб filed Critical Астразенека Аб

2012-06-11 Publication of UA98676C2 publication Critical patent/UA98676C2/ru

Links

229920000168 Microcrystalline cellulose Polymers 0.000 title abstract 2
235000019813 microcrystalline cellulose Nutrition 0.000 title abstract 2
239000008108 microcrystalline cellulose Substances 0.000 title abstract 2
229940016286 microcrystalline cellulose Drugs 0.000 title abstract 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 title 1
229930195725 Mannitol Natural products 0.000 title 1
FJHHZXWJVIEFGJ-UHFFFAOYSA-N N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide Chemical compound COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=2OC=NN=2)C=C1 FJHHZXWJVIEFGJ-UHFFFAOYSA-N 0.000 title 1
239000000594 mannitol Substances 0.000 title 1
235000010355 mannitol Nutrition 0.000 title 1
229950003684 zibotentan Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

UAA201005506A 2007-10-12 2008-10-09 Композиция зиботентана, содержащая маннит и микрокристаллическую целлюлозу UA98676C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US97973607P	2007-10-12	2007-10-12

Publications (1)

Publication Number	Publication Date
UA98676C2 true UA98676C2 (ru)	2012-06-11

Family

ID=50847025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA201005506A UA98676C2 (ru)	2007-10-12	2008-10-09	Композиция зиботентана, содержащая маннит и микрокристаллическую целлюлозу

Country Status (1)

Country	Link
UA (1)	UA98676C2 (ru)

2008
- 2008-10-09 UA UAA201005506A patent/UA98676C2/ru unknown

Similar Documents

Publication	Publication Date	Title
MX2010003989A (es)	2010-04-27	Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
DK1874306T3 (da)	2012-10-01	Sammensætninger af en oralt aktiv 1,2,4-oxadiazol til nonsens-mutationssuppressionsterapi
UA94964C2 (ru)	2011-06-25	Производные 5-замещенного хиназолинона, композиция, которая их содержит, и их применение
CL2007002930A1 (es)	2008-04-04	Un compuesto 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridin-2-carboxamida monohidratado; proceso de preparacion; composicion y combinacion farmaceutica; y uso para el tratamiento de trastornos hiperproliferati
CL2011002697A1 (es)	2012-06-01	Compuestos derivados de 3-[4-(oxo-dihidropiridin)bencil]-1,3-oxazin-ona hidratados, inhibidores 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes
DK1954684T3 (da)	2014-06-30	Oxazol forbindelse og farmaceutisk sammensætning.
MY150647A (en)	2014-02-14	1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
MX2009006579A (es)	2009-07-22	4-{4-[({3-terbutil-1-[3-(hidroximetil]fenil]-1h-pirazol-5-il}carb amoil)-amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida asi como precursores y sales de los mismos para el tratamiento de cancer.
GEP20156348B (en)	2015-08-25	Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
WO2007112014A3 (en)	2007-12-21	New therapeutic combinations for the treatment of depression
MX2010004688A (es)	2010-09-09	Usos terapeuticos de compuestos que tienen actividad combinada de sert, 5- ht3 y 5-ht1a.
TW200716628A (en)	2007-05-01	Novel compounds
CL2007000918A1 (es)	2008-02-08	Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
CL2011003138A1 (es)	2012-06-22	N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion.
IS7766A (is)	2005-03-22	N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-[1,3,4-oxadíasól-2-ýl]fenýl)pýridín-3-súlfónamíð sem krabbameinslyf
MX2010005795A (es)	2010-08-31	Usos terapeuticos de compuestos con afinidad con el transportador de serotonina, los receptores de serotonina y el transportador de noradrenalina.
ZA200704104B (en)	2008-09-25	A combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer
CY1110942T1 (el)	2015-06-10	Αλας αιθανολαμινης n-(3-μεθοξυ-αιθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολο -2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδιου
IL179346A0 (en)	2007-03-08	3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
WO2007068728A3 (en)	2007-09-27	N-substituted pyrrolopyridinones active as kinase inhibitors
PE20060353A1 (es)	2006-07-08	Combinacion farmaceutica antituberculosa que comprende n-(3-[[4-(3-trifluorometilfenil)piperazinil]metil]-2-metil-5-fenil-pirrolil)-4-piridilcarboxamida
WO2009068906A3 (en)	2009-07-23	Combinations comprising zd4054 and a src family kinase inhibitor 172
DK1906926T3 (da)	2011-01-31	Farmaceutisk sammensætning omfattende 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolderivater
WO2006122012A3 (en)	2007-03-08	Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
EA200970167A1 (ru)	2009-08-28	Фармацевтическая композиция, содержащая комбинацию саредутанта и селективного ингибитора обратного захвата серотонина или ингибитора обратного захвата серотонина/норэпинефрина